2014
Unresolved pulmonary embolism leading to a diagnosis of pulmonary artery sarcoma
Gutiérrez A, Sauler M, Mitchell JM, Siegel MD, Trow TK, Bacchetta M, Fares WH. Unresolved pulmonary embolism leading to a diagnosis of pulmonary artery sarcoma. Heart & Lung 2014, 43: 574-576. PMID: 24928184, DOI: 10.1016/j.hrtlng.2014.05.006.Peer-Reviewed Case Reports and Technical NotesConceptsPulmonary artery sarcomaPulmonary embolismPresumed pulmonary embolismUnresolved pulmonary embolismCT pulmonary angiogramAnticoagulation treatmentProgressive symptomsPulmonary angiogramSurgical resectionPulmonary arteryPoor prognosisRare tumorAdditional imagingDifferential diagnosisProper diagnosisEmbolismSarcomaDiagnosisResectionPatientsDyspneaArteryPrognosisAngiogramsMetastasis
2013
Diagnosis of Pulmonary Arterial Hypertension
Forfia PR, Trow TK. Diagnosis of Pulmonary Arterial Hypertension. Clinics In Chest Medicine 2013, 34: 665-681. PMID: 24267297, DOI: 10.1016/j.ccm.2013.09.001.Peer-Reviewed Original ResearchConceptsPulmonary arterial hypertensionArterial hypertensionPulmonary venous hypertensionPopulation of patientsEchocardiographic cluesNonpharmacologic managementPulmonary hypertensionRight shuntingVenous hypertensionCardiac catheterizationClinical suspicionRight heartNoninvasive testsPhysical examLeft heartHigh indexHypertensionAccurate diagnosisDiagnosisCareful assessmentCatheterizationHeartPatientsShuntingSuspicionStandard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension
Sauler M, Fares WH, Trow TK. Standard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension. Clinics In Chest Medicine 2013, 34: 799-810. PMID: 24267305, DOI: 10.1016/j.ccm.2013.08.013.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHigh-dose calcium channel blockersCommon cardiopulmonary diseasesPAH-specific therapyPulmonary arterial hypertensionTreatment of patientsCalcium channel blockersPAH therapyArterial hypertensionAdjunct therapyOxygen therapyMedical therapyNonspecific therapyCardiopulmonary diseasePathologic understandingChannel blockersSmall studyTherapyHypertension researchExpert opinionAnticoagulationHypertensionDiureticsPatientsBlockersDigoxin
2012
Targeted approaches to the treatment of pulmonary hypertension
Fares WH, Trow TK. Targeted approaches to the treatment of pulmonary hypertension. Therapeutic Advances In Respiratory Disease 2012, 6: 147-159. PMID: 22438264, DOI: 10.1177/1753465812441849.Peer-Reviewed Original ResearchConceptsPulmonary arterial hypertensionArterial hypertensionHigh-dose calcium channel blockersChest Physicians criteriaMultiple therapeutic optionsDurability of responseCalcium channel blockersTransplant evaluationPulmonary hypertensionOral therapyClose followPhysician's criteriaTherapeutic optionsChannel blockersEarly initiationAmerican CollegeHigh riskPatientsIncurable diseaseHypertensionEarly useStatus benefitsTreatmentDiseaseProgression
2011
Pregnancy and Pulmonary Hypertension
Lane CR, Trow TK. Pregnancy and Pulmonary Hypertension. Clinics In Chest Medicine 2011, 32: 165-174. PMID: 21277457, DOI: 10.1016/j.ccm.2010.10.006.Peer-Reviewed Original ResearchReproducibility of Oxygen Saturation Monitoring During Six-Minute Walk Test and Exercise Stress Test in Patients with Pulmonary Arteriovenous Malformations Associated With Hereditary Hemorrhagic Telangiectasia
Li W, Niu B, Henderson K, Northrup V, Pollak JS, Trow T, Fahey J, White RI. Reproducibility of Oxygen Saturation Monitoring During Six-Minute Walk Test and Exercise Stress Test in Patients with Pulmonary Arteriovenous Malformations Associated With Hereditary Hemorrhagic Telangiectasia. Pediatric Cardiology 2011, 32: 590-594. PMID: 21336824, DOI: 10.1007/s00246-011-9917-8.Peer-Reviewed Original ResearchConceptsPulmonary arteriovenous malformationsHereditary hemorrhagic telangiectasiaOxygen saturationHeart rateWalk testArteriovenous malformationsHemorrhagic telangiectasiaSix-minute walk testOxygen saturation monitoringLowest oxygen saturationYears of ageHuman Investigation CommitteeStress testIntraclass correlation coefficientAnatomic subtypesExercise capacityMultiple complicationsPatientsAdjunct testSaturation monitoringAdequate restReproducible measureMalformationsTelangiectasiaBroad spectrum
2010
Chronic Thromboembolic Pulmonary Hypertension
Auger WR, Kim NH, Trow TK. Chronic Thromboembolic Pulmonary Hypertension. Clinics In Chest Medicine 2010, 31: 741-758. PMID: 21047580, DOI: 10.1016/j.ccm.2010.07.006.Peer-Reviewed Original ResearchConceptsChronic thromboembolic pulmonary hypertensionThromboembolic pulmonary hypertensionPulmonary hypertensionSpecific medical therapySmall vessel arteriopathyMedical therapyPreoperative evaluationMechanical obstructionPulmonary vasculatureAcute embolusRisk factorsHypertensionPatientsNatural historyPutative mechanismsLimited dataSole causeArteriopathyEndartectomyEmboliObstructionTherapyNoncandidatesEpidemiologyDiagnosis
2007
Pulmonary Hypertension in the Elderly: More Common Than We Thought?
Mannam P, Trow T. Pulmonary Hypertension in the Elderly: More Common Than We Thought? Clinical Pulmonary Medicine 2007, 14: 240-242. DOI: 10.1097/cpm.0b013e3180cac701.Peer-Reviewed Original Research
2006
Radiology–Pathology Conference: sclerosing hemangioma of the lung
Neuman J, Rosioreanu A, Schuss A, Turi G, Yung E, Trow TK, Williams L, Katz DS. Radiology–Pathology Conference: sclerosing hemangioma of the lung. Clinical Imaging 2006, 30: 409-412. PMID: 17101410, DOI: 10.1016/j.clinimag.2006.05.030.Peer-Reviewed Original ResearchConceptsFluorodeoxyglucose positron emission tomography (FDG-PET) findingsPositron emission tomography findingsCharacteristic imaging findingsDefinitive diagnostic testTomography findingsImaging findingsUnusual tumorBenign neoplasmsDiagnostic testsHemangiomaLungPatientsBiopsyNeoplasmsTumorsFindingsPathology
2005
Surviving Pulmonary Hypertension: An Oral Alternative?
Castiller F, Trow T. Surviving Pulmonary Hypertension: An Oral Alternative? Clinical Pulmonary Medicine 2005, 12: 281-282. DOI: 10.1097/01.cpm.0000171504.71068.5a.Peer-Reviewed Original ResearchTreatment of pulmonary arterial hypertensionPrimary pulmonary hypertensionEndothelin receptor blockersPulmonary arterial hypertensionPulmonary hypertensionArterial hypertensionIntravenous alternativeOral alternativeReceptor blockersImproved survivalAdvanced hypertensionHypertensionBosentanSurvivalPatientsBlockersEndothelinTreating Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension: Is Endothelin 1 a Target?
Trow T. Treating Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension: Is Endothelin 1 a Target? Clinical Pulmonary Medicine 2005, 12: 196-197. DOI: 10.1097/01.cpm.0000163121.24487.48.Peer-Reviewed Original ResearchHuman immunodeficiency virus-associated pulmonary arterial hypertensionNew York Heart Association functional classPulmonary arterial hypertensionPulmonary hypertensionCardiopulmonary hemodynamicsQuality-of-life measuresArterial hypertensionEndothelin-1Treated patientsDrug interactionsSide effectsFunctional classBosentanWalking distanceHypertensionEndothelinPatientsHemodynamics“Best PEEP” Therapy in the Injured Lung
Khan S, Trow T. “Best PEEP” Therapy in the Injured Lung. Clinical Pulmonary Medicine 2005, 12: 56-57. DOI: 10.1097/01.cpm.0000151449.01435.ab.Peer-Reviewed Original Research
2004
Live “Free” or Die: Total or Free Serum Cortisol Measure in the Critically Ill
de León D, Trow T. Live “Free” or Die: Total or Free Serum Cortisol Measure in the Critically Ill. Clinical Pulmonary Medicine 2004, 11: 338-340. DOI: 10.1097/01.cpm.0000140185.13083.a1.Peer-Reviewed Original ResearchSerum total cortisolCritically ill patientsIll patientsTotal cortisolSerum free cortisol levelsAdequate adrenal responseSerum free cortisolFree cortisol levelsSerum cortisol measurementsFree cortisolAdrenal responseCritically Ill.Protein statusPatientsInterpretation of baselineCortisol levelsCortisol measurementsVentilating the Obese Patient With Acute Lung Injury: Should the Strategy Be Different Than That Adopted for the Patient of Normal Weight?
Anderson J, Trow T. Ventilating the Obese Patient With Acute Lung Injury: Should the Strategy Be Different Than That Adopted for the Patient of Normal Weight? Clinical Pulmonary Medicine 2004, 11: 262-264. DOI: 10.1097/01.cpm.0000133057.87989.c3.Peer-Reviewed Original ResearchAcute lung injuryLung injuryObese patientsLow tidal volume strategyPatients of normal weightNormal body mass indexTidal volume strategyExcess body weightMechanically ventilated patientsBody mass indexAssociated with outcomeNormal weightMass indexVolume strategyPatientsBody weightInjuryOutcomesObesityAcute